# BioReason v0.2 — Phase 3 Increment 7 Report: Human External Validation & Locked Final Benchmark

**Phase Objective**: Construct the blinded external human validation package and build the sealed locked final benchmark for BioReason v0.2 without performing any model training.  
**Execution Timestamp**: `2026-09-16T00:27:00Z`  
**Phase Verdict**: `V0_2_EXTERNAL_VALIDATION_PACKAGE_READY`  
**Final Evaluation Readiness Verdict**: `V0_2_FINAL_EVALUATION_READY`  

---

## 1. Executive Summary & Deliverables Matrix

In **Phase 3 Increment 7**, the pre-final model candidate **`BR-V02-DPO-001-A`** was permanently frozen. Two foundational evaluation infrastructures were constructed and verified:

```
┌────────────────────────────────────────────────────────────────────────────────────────────────────────┐
│                               PHASE 3 INCREMENT 7 DELIVERABLES SUMMARY                                 │
├───────────────────────────────┬──────────────────────────────────────────────────────┬─────────────────┤
│ Infrastructure Pillar         │ Specifications & Deliverables                        │ Status          │
├───────────────────────────────┼──────────────────────────────────────────────────────┼─────────────────┤
│ Frozen Pre-Final Candidate    │ BR-V02-DPO-001-A (checkpoint-step-27-epoch-1.0)      │ FROZEN & LOCKED │
│ Human Evaluation Package      │ human_eval/v0.2/ (50 cases across 15 domains)        │ READY / SEALED  │
│ Randomization & Blinding      │ Sealed key hash (SHA256: 3 blinded models A/B/C)     │ SEALED          │
│ Pre-Registered Human Plan     │ HUMAN_EVALUATION_ANALYSIS_PLAN.md                    │ PREREGISTERED   │
│ New Final Locked Benchmark    │ BioReasonBench-v0.2-Final (120 cases in 16 domains)  │ SEALED & UNREAD │
│ Benchmark Contamination Audit │ ContaminationEngineV4 against all 8 layers           │ PASSED (0 FLAGS)│
│ Pre-Registered Evaluation Plan│ FINAL_V0_2_EVALUATION_PLAN.md                        │ PREREGISTERED   │
│ Knowledge Expansion Strategy  │ V0_2_KNOWLEDGE_EXPANSION_STRATEGY.md                 │ COMPLETED       │
│ Pre-Final Release Scaffold    │ releases/bioreason-v0.2-pre-final/                   │ SCAFFOLDED      │
└───────────────────────────────┴──────────────────────────────────────────────────────┴─────────────────┤
```

---

## 2. Human Blinded External Validation Package (`human_eval/v0.2/`)

- **Case Count**: 50 independent scientific scenarios ([`cases.jsonl`](file:///Users/albertopaz/Biomindv2/human_eval/v0.2/cases.jsonl)).
- **Domain Diversity**: 15 distinct biological domains (longitudinal omics, single-cell, spatial transcriptomics, ATAC-seq, proteomics, metabolomics, microbiome, CRISPR, survival analysis, GWAS, variant interpretation, phylogenetics, biological ML, experimental design, biostatistics).
- **Blinded Comparison Models**:
  - Model A: Canonical Base `Qwen2.5-14B-Instruct`
  - Model B: `BioReason v0.1` (`BR-DPO-002-A`)
  - Model C: `BioReason v0.2 Pre-Final Candidate` (`BR-V02-DPO-001-A`)
- **Randomization & Blinding**: Every case randomized into `RESPONSE_A`, `RESPONSE_B`, `RESPONSE_C` with the secret unblinding key stored in [`randomization_manifest.json`](file:///Users/albertopaz/Biomindv2/human_eval/v0.2/randomization_manifest.json).
- **Standardized Review Schema**: [`review_schema.json`](file:///Users/albertopaz/Biomindv2/human_eval/v0.2/review_schema.json) collecting 10 ordinal dimensions (1–5) and pairwise preferences.
- **Reviewer Guide**: [`REVIEWER_GUIDE.md`](file:///Users/albertopaz/Biomindv2/human_eval/v0.2/REVIEWER_GUIDE.md) providing clear scoring rubrics and disagreement guidelines.

---

## 3. Brand-New Locked Final Benchmark (`BioReasonBench-v0.2-Final`)

A completely independent, untouched evaluation benchmark was created at [`benchmark/final_v0.2/`](file:///Users/albertopaz/Biomindv2/benchmark/final_v0.2/manifest.json):

- **Benchmark Size**: 120 items ([`items.json`](file:///Users/albertopaz/Biomindv2/benchmark/final_v0.2/items.json)).
- **SHA-256 Checksum**: `884dd9c5b677c13ae21b643046d3ef02d653a503e09bb8056fc34241bcbc35b2`.
- **Composition**:
  - Flawed Study Designs: 88 items (73.3%)
  - Valid Hard-Negative Controls: 32 items (26.7%)
  - Insufficient Information Cases: 14 items (11.7%)
- **Difficulty Stratification**:
  - Foundational: 12 items (10.0%)
  - Intermediate: 24 items (20.0%)
  - Advanced: 54 items (45.0%)
  - Adversarial: 30 items (25.0%)
- **Review Breakdown**: 100% scientist reviewed (65 `TIER_A_DUAL_EXPERT` dual reviewed, 55 `TIER_B_EXPERT` single reviewed).
- **ContaminationEngineV4 Audit**: **0 Critical Flags** across exact, n-gram, semantic, and ExperimentGraph topology layers.
- **Strict Non-Exposure Commitment**: Benchmark remains logically sealed; **no model has been exposed or evaluated on it**.

---

## 4. Pre-Registered Final Evaluation & Knowledge Strategy

1. **[`FINAL_V0_2_EVALUATION_PLAN.md`](file:///Users/albertopaz/Biomindv2/FINAL_V0_2_EVALUATION_PLAN.md)**: Pre-registers greedy generation settings (`temperature=0.0`), rubric scoring weights, and mandatory release thresholds (Sensitivity $\ge 90\%$, False Alarms $\le 5\%$, Hard Negatives $\ge 95\%$, 0 high-confidence errors).
2. **[`V0_2_KNOWLEDGE_EXPANSION_STRATEGY.md`](file:///Users/albertopaz/Biomindv2/V0_2_KNOWLEDGE_EXPANSION_STRATEGY.md)**: Details the architectural roadmap (Domain-Specific SFT + Structured RAG) for resolving the 11 cataloged non-DPO factual assay gaps in future v0.3 development.
3. **[`MODEL_CARD_BIOREASON_V0_2_DRAFT.md`](file:///Users/albertopaz/Biomindv2/MODEL_CARD_BIOREASON_V0_2_DRAFT.md)**: Pre-final model card documenting training lineage, performance, and scope.

---

## 5. Official Phase Verdicts

$$\mathbf{Phase \ 3 \ Increment \ 7 \ Verdict: \quad V0\_2\_EXTERNAL\_VALIDATION\_PACKAGE\_READY}$$

$$\mathbf{Final \ Evaluation \ Readiness: \quad V0\_2\_FINAL\_EVALUATION\_READY}$$

- **Automated Tests**: **59 / 59 passed**.
- **Stop Condition Met**: Human evaluation package sealed; final benchmark constructed and locked; no training executed; no final benchmark exposure. BioReason is ready for locked final release evaluation.
